| 1 |
34886743 | Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines. | 2022 |
1 |
| 2 |
27678008 | Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia. | 2017 Dec |
1 |
| 3 |
24057147 | Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells. | 2014 Jan |
3 |
| 4 |
24144307 | The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan. | 2014 Jul |
2 |
| 5 |
23585524 | ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin. | 2013 Jul |
1 |
| 6 |
22149137 | The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. | 2012 Jul |
1 |
| 7 |
22369572 | Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. | 2012 Sep |
1 |
| 8 |
23091097 | Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. | 2012 Dec 20 |
1 |
| 9 |
20933509 | The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. | 2011 Jan 15 |
2 |
| 10 |
21270755 | DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells. | 2010 Dec |
2 |
| 11 |
19018867 | Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. | 2009 Feb |
1 |
| 12 |
16543464 | Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. | 2006 Aug 1 |
2 |